Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus l-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL)
Crossref DOI link: https://doi.org/10.1007/s00277-014-2228-4
Published Online: 2014-10-11
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Miso
Kim, Tae Min
Kim, Ki Hwan
Keam, Bhumsuk
Lee, Se-Hoon
Kim, Dong-Wan
Lee, Jong Seok
Jeon, Yoon Kyung
Kim, Chul Woo
Heo, Dae Seog
Text and Data Mining valid from 2014-10-11